Alexandria Real Estate Equities, Inc. · NYSE:ARE
Alexandria Real Estate Equities — Q3 2025 Earnings Presentation
62 slides from Alexandria Real Estate Equities's earnings presentation, Oct 27, 2025
Slide 1: Reserved . © 2025
Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2025
Slide 2: Alexandria executes largest life science lease in company history
ALEXANDRIA EXECUTES LARGEST LIFE SCIENCE LEASE IN COMPANY HISTORY WITH A LONG-STANDING MULTINATIONAL PHARMACEUTICAL TENANT FOR A 466,598 RSF BUILD-TO-SUIT RESEARCH HUB AT THE CAMPUS POINT MEGACAMPUS ™ IN SAN DIEGO Our long-term lease with a high-credit tenant underscores the strength and uniqueness
Slide 3: Reserved. © 2025 iv
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2025 iv
Slide 4: Reserved. © 2025 v
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2025 v
Slide 5: Alexandria: the most trusted brand in life science real estate
ALEXANDRIA: THE MOST TRUSTED BRAND IN LIFE SCIENCE REAL ESTATE ™ WE INVENTED IT. WE DOMINATE IT. ALEXANDRIA’S MEGACAMPUS ™ PLATFORM REPRESENTS 77% OF OUR ANNUAL RENTAL REVENUE LARGEST, HIGHEST-QUALITY ASSET BASE CLUSTERED IN THE KEY CENTERS OF LIFE SCIENCE INNOVATION SECTOR-LEADING CLIENT BASE OF ~
Slide 6: Megacampus platform drives superior operating results
ALEXANDRIA’S MEGACAMPUS ™ PLATFORM DRIVES SUPERIOR OPERATING RESULTS BY CLUSTERING HIGH-QUALITY COLLABORATIVE LIFE SCIENCE AND ADVANCED TECHNOLOGIES FACILITIES IN TOP INNOVATION MARKETS ALEXANDRIA’S MEGACAMPUS OCCUPANCY OUTPERFORMS THE MARKET (1) ALEXANDRIA’S MEGACAMPUS PLATFORM 77% of Annual Rental
Slide 7: (1) Source: U.S. House Committee on Energy and Commerce, “The 21st Century Cures Discussion
(1) Source: U.S. House Committee on Energy and Commerce, “The 21st Century Cures Discussion Document White Paper,” January 27, 2015. Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2025 viii
Slide 8: Reserved. © 2025 ix
Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2025 ix
Slide 9: NBI TSR tracks the S&P 500 index TSR
(1) Source: U.S. House Committee on Energy and Commerce, “The 21st Century Cures Discussion Document White Paper,” January 27, 2015. (2) Source: PhRMA, “Medicines in Development for Chronic Diseases: 2024 Report.” (3) Source: Centers for Disease Control and Prevention, “Heart Disease Facts,” October
Slide 10: Slide 10
Slide 11: NBI, S&P Index and ARE TSR
NBI TSR 1,441% S&P 500 Index TSR 1,221% ARE TSR 1,064%
Slide 12: Novel therapies approved by the FDA
(1) Source: U.S. Food and Drug Administration. Novel therapies approved by the FDA (Center for Drug Evaluation and Research) include new molecular entities and new biologics defined as products containing active moieties that have not previously been approved by the FDA. (1) Includes two additional
Slide 13: Life science industry and corporate responsibility leadership
ALEXANDRIA’S LIFE SCIENCE INDUSTRY AND CORPORATE RESPONSIBILITY LEADERSHIP Alexandria Real Estate Equities, Inc. All Rights Reserved. © 2025 xiii 2025 RECYCLED ASSETS SOLD OR TO BE SOLD TO FUND OUR CAPITAL NEEDS AND ENABLE ACHIEVEMENT OF 80% ANNUAL RENTAL REVENUE FROM MEGACAMPUSES
Slide 14: 2025 recycled assets sold to fund capital needs
$87M REDUCTION IN ANNUAL NET OPERATING INCOME (1) FROM 2025 DISPOSITIONS (2) 32 TOTAL TRANSACTIONS (2) $1.5B TOTAL SALES (2)
Slide 15: 2025 dispositions by real estate classification
Stabilized Properties Land 20% to 30% 20% to 30% 40% to 60% Non-stabilized Properties 2025 DISPOSITIONS BY REAL ESTATE CLASSIFICATION (2) (1) Represents annual net operating income for the quarter preceding the date on which the property is sold, or near-term prospective net operating income. (2) Re
Slide 16: 2019 – YTD 3Q25 dispositions and partial interest sales
2019 – YTD 3Q25 AGGREGATE $10B Total Proceeds (1) $3.6B Total Gains on Sales of Real Estate (2) $1.4B Total Impairments of Real Estate (2) 2019 – YTD 3Q25 DISPOSITIONS AND PARTIAL INTEREST SALES (1) Represents aggregate proceeds from outright sales and sales of partial interests. (2) Total gains and
Slide 17: G&A expenses: Alexandria vs S&P REITs
ALEXANDRIA S&P 500 REITS (excluding Alexandria)
Slide 18: 2023 2024 9/30/2025
2023 2024 9/30/2025
Slide 19: 6/30/2025
6/30/2025
Slide 20: G&A expenses as a percentage of net operating income
(1) (1) GENERAL AND ADMINISTRATIVE EXPENSES AS A PERCENTAGE OF NET OPERATING INCOME (2) Source for S&P 500 REIT data: S&P Global Market Intelligence. (1) Trailing twelve months ended September 30, 2025 and June 30, 2025, respectively. Refer to “2026 Considerations” in the Earnings Release for additi
Slide 21: Reports 3Q25 and YTD 3Q25 results
Alexandria Real Estate Equities, Inc. Reports: 3Q25 and YTD 3Q25 Net Loss per Share – Diluted of $(1.38) and $(2.09) , respectively ; and 3Q25 and YTD 3Q25 FFO per Share – Diluted, as Adjusted, o f $2.22 and $6.85 , respectively PASADENA, Calif. – October 27, 2025 – Alexandria Real Estate Equities,
Slide 22: Tenant mix by percentage of annual rental revenue
Life Science Product, Service, and Device Multinational Pharmaceutical Public Biotechnology – Approved or Marketed Other (1) Advanced Technologies (2) Public Biotechnology – Preclinical or Clinical Stage Government Institutions Biomedical Institutions (3) Private Biotechnology Percentage of ARE’s An
Slide 23: 2024 YTD
16.9% 13.6% 2024 YTD 9/30/25
Slide 24: 2024 YTD
4.6% 3.0% 2024 YTD 9/30/25 Cash Basis
Slide 25: 2024 YTD
7.2% 6.8% 2024 YTD 9/30/25 Cash Basis
Slide 26: Same property performance
(3.1)% 2024 YTD 9/30/25 (1) Refer to “Same property performance” and “Definitions and reconciliations” in the Supplemental Information for additional details. “Definitions and reconciliations” contains the definition of “Net operating income” and its reconciliation from the most directly comparable
Slide 27: 2.00% 0.00% -2.00% -4.00% -6.00% -8.00% -10.00% 1025 2025 25 —eAs Reported 3025 Same
2.00% 0.00% -2.00% -4.00% -6.00% -8.00% -10.00% 1025 2025 3025 —eAs Reported 3025 Same Properties
Slide 28: Percentage change in same property performance
Net Operating Income Net Operating Income (Cash Basis) Percentage Change in Same Property Performance 1Q25 2Q25 3Q25 1Q25 2Q25 3Q25 As reported (3.1)% (5.4)% (6.0)% 5.1% 2.0% (3.1)% 3Q25 same properties 0.3% (2.5)% (6.0)% 8.0% 5.6% (3.1)% Refer to “ Same property comparisons ” under “Definitions and
Slide 29: Development and redevelopment deliveries expected to provide incremental NOI growth
ALEXANDRIA’S DEVELOPMENT AND REDEVELOPMENT DELIVERIES ARE EXPECTED TO PROVIDE INCREMENTAL GROWTH IN ANNUAL NET OPERATING INCOME Placed Into Service Near-Term Deliveries YTD 3Q25 4Q25 – 4Q26 $68M $111M 94% Occupied 80% Leased/Negotiating 712,785 RSF 969,524 RSF (2) (1) (3) (4) Refer to “Net operating
Slide 30: Non-income-producing assets
Projects under active construction with stabilization in 2025-2027 and beyond and one 100% pre-leased committed near-term project expected to commence in the next year – $3.7 billion 20% Non-Income- Producing Assets Future development projects (5) and land parcels, primarily located in Megacampuses
Slide 31: Slide 31
Slide 32: Recent deliveries
230 Harriet Tubman Way 10935, 10945, and 10955 Alexandria Way (2) 10075 Barnes Canyon Road San Francisco Bay Area/ South San Francisco San Diego/Torrey Pines San Diego/Sorrento Mesa 285,346 RSF 334,996 RSF 31,490 RSF 100% Occupancy 100% Occupancy 100% Occupancy
Slide 33: wAN
wAN ALEXANDRIA centet) i sun = CHANGING INNOVATION FUTU} BUILDIN,
Slide 34: Slide 34
Slide 35: New Class A/A+ properties: recent deliveries
(1) Image represents 500 North Beacon Street on The Arsenal on the Charles Megacampus. (2) Image represents 10955 Alexandria Way on the One Alexandria Square Megacampus. Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2025 35 New Class A/A+ Development and Redevelopment Properties: Rec
Slide 36: Slide 36
Slide 37: Near-term deliveries
10075 Barnes Canyon Road 8800 Technology Forest Place San Diego/Sorrento Mesa Texas/Greater Houston 221,589 RSF 73,298 RSF 68% Leased/Negotiating 41% Leased/Negotiating
Slide 38: Slide 38
Slide 39: Key properties: 2027 and beyond stabilization
Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2025 37 Key New Class A/A+ Development and Redevelopment Properties: 2027 and Beyond Stabilization (Intermediate-Term Deliveries)
Slide 40: Slide 40
Slide 41: Slide 41
Slide 42: | | i) tess
| | i) tess a) fill HESS ype wl aml ais aiden AtEm i fees hee We
Slide 43: Intermediate-term delivery properties
1450 Owens Street 651 Gateway Boulevard 269 East Grand Avenue 701 Dexter Avenue North San Francisco Bay Area/ Mission Bay San Francisco Bay Area/ South San Francisco San Francisco Bay Area/ South San Francisco Seattle/Lake Union 212,796 RSF 237,684 RSF 107,250 RSF 227,577 RSF
Slide 44: Slide 44
Slide 45: Slide 45
Slide 46: < Lijee a i. ‘al pelt
Ji < Lijee a i. 2 ‘al pelt
Slide 47: New Class A/A+ properties: current projects
(1) Image represents 60 Sylvan Road on the Alexandria Center ® for Life Science – Waltham Megacampus. The project is expected to capture demand in our Route 128 submarket. Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2025 38 New Class A/A+ Development and Redevelopment Properties: C
Slide 48: Average real estate basis capitalized YTD 3Q25
Smaller redevelopments and repositioning of capital projects (1) – $1.1 billion Under construction – 2025 and 2026 stabilization – $650.0 million ( 80% leased/negotiating) Critical milestones in 4Q25 and 2026 – Future Megacampus projects (2) – $3.0 billion Under construction and committed near-term
Slide 49: Capitalization of interest (continued)
1.4M RSF ACTIVE/FUTURE 100% Pre-Leased Committed Near- Term Development Refer to “ Megacampus™ ” under “Definitions and reconciliations” in the Supplemental Information for additional details. Represents total square footage upon completion of development or redevelopment of one or more new Class A/
Slide 50: Capitalization of interest (continued)
1.5M RSF FUTURE Refer to “ Megacampus™ ” under “Definitions and reconciliations” in the Supplemental Information for additional details. Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RSF
Slide 51: Capitalization of interest (continued)
1.3M RSF ACTIVE/FUTURE Refer to “ Megacampus™ ” under “Definitions and reconciliations” in the Supplemental Information for additional details. Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes
Slide 52: Capitalization of interest (continued)
1.9M RSF FUTUR E Refer to “ Megacampus™ ” under “Definitions and reconciliations” in the Supplemental Information for additional details. Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes the RS
Slide 53: Slide 53
Slide 54: Investments
13% Public 21% Tenant 87% Private 79% Non-Tenant (1) Consists of realized gains of $34.8 million and $94.7 million , partially offset by impairment charges o f $25.1 million and $75.5 million during the three and nine months ended September 30, 2025 , respectively. (2) Consists of realized gains of
Slide 55: Significant liquidity and fixed-rate debt
SIGNIFICANT LIQUIDITY PERCENTAGE OF FIXED-RATE DEBT SINCE 2021 (1) $4.2B 96.7% REMAINING DEBT TERM (IN YEARS) DEBT INTEREST RATE 11.6 3.97% Longest Among S&P 500 REITs (3) TOP 15% CREDIT RATING RANKING AMONG ALL PUBLICLY TRADED U.S. REITS (2) BBB+ Stable Baa1 Negative WEIGHTED AVERAGE As of Septembe
Slide 56: Liquidity and leverage
(in millions) Availability under our unsecured senior line of credit, net of amounts outstanding under our commercial paper program $ 3,450 Cash, cash equivalents, and restricted cash 584 Investments in publicly traded companies 124 Liquidity as of September 30, 2025 $ 4,158 Net Debt and Preferred S
Slide 57: Net debt to adjusted EBITDA targets
6.1x 5.2x 12/31/24 9/30/25 12/31/25 Target
Slide 58: Summary of debt
5.5x to 6.0x 3.6x to 4.1x Refer to “Definitions and reconciliations” in the Supplemental Information for additional details. (1) Quarter annualized. Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2025 56 Summary of Debt
Slide 59: Summary of debt (continued)
(1) We expect to have limited borrowings, with less than $500.0 million outstanding on our unsecured senior line of credit and commercial paper program by the end of 2025. We expect to reduce the outstanding balance with proceeds from our 2025 dispositions expected to close in 4Q25. Refer to “Dispos
Slide 60: Slide 60
Slide 61: Remaining debt term vs S&P REITs
14.0 12.0 11.6 10.0 8.0 6.0 4.0 2.0 b0 3.204.104.404.484.504.504.7 5.1 95.2 05.4095.695.8 65.8 6.5 6.76.7 7,087.1 87.5 8.7 SBAC BXP DOC EXR IRM DLR UDR VTR CPT INVH HST AMTWELL O FRT CCI VICI ESS EQIXMAA AVB EQR REG SPG KIM PLD ARE
Slide 62: Average debt term of S&P REITs
5.8 Years Average Debt Term of S&P 500 REITs as of June 30, 2025
Alexandria Real Estate Equities — Q3 2025 Earnings Presentation on 6ix